Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors.

Woerner A, Sauvain MJ, Aebi C, Otth M, Bolt IB.

Hum Vaccin. 2011 Dec;7(12):1293-8. doi: 10.4161/hv.7.12.17981. Epub 2011 Dec 1.

PMID:
22185812
[PubMed - indexed for MEDLINE]
Free Article
2.

The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination.

Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, Rimmelzwaan GF, Kroon FP.

Ann Rheum Dis. 2008 May;67(5):713-6. Epub 2007 Oct 26.

PMID:
17965123
[PubMed - indexed for MEDLINE]
3.

Immune response to influenza vaccine in children with inflammatory bowel disease.

Lu Y, Jacobson DL, Ashworth LA, Grand RJ, Meyer AL, McNeal MM, Gregas MC, Burchett SK, Bousvaros A.

Am J Gastroenterol. 2009 Feb;104(2):444-53. doi: 10.1038/ajg.2008.120. Epub 2009 Jan 27.

PMID:
19174786
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease.

deBruyn JC, Hilsden R, Fonseca K, Russell ML, Kaplan GG, Vanderkooi O, Wrobel I.

Inflamm Bowel Dis. 2012 Jan;18(1):25-33. doi: 10.1002/ibd.21706. Epub 2011 Apr 6.

PMID:
21472826
[PubMed - indexed for MEDLINE]
5.

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.

Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.

Pediatrics. 2006 Sep;118(3):e579-85.

PMID:
16950949
[PubMed - indexed for MEDLINE]
Free Article
6.

Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.

Zuccotti G, Amendola A, Viganò A, Pariani E, Zappa A, Pogliani L, Giacomet V, Savarino A, Podestà A, Rottoli A, Tanzi E, Zanetti A, Radaelli G.

Vaccine. 2007 Sep 17;25(37-38):6692-8. Epub 2007 Jul 27.

PMID:
17697730
[PubMed - indexed for MEDLINE]
7.

Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.

Pediatrics. 2006 Sep;118(3):e570-8.

PMID:
16950948
[PubMed - indexed for MEDLINE]
Free Article
8.

Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.

Adler S, Krivine A, Weix J, Rozenberg F, Launay O, Huesler J, Guillevin L, Villiger PM.

Rheumatology (Oxford). 2012 Apr;51(4):695-700. doi: 10.1093/rheumatology/ker389. Epub 2011 Dec 14.

PMID:
22171015
[PubMed - indexed for MEDLINE]
Free Article
9.

Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.

Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, Baldassano RN.

Clin Gastroenterol Hepatol. 2007 Jul;5(7):851-6. Epub 2007 Jun 4.

PMID:
17544875
[PubMed - indexed for MEDLINE]
10.

Kinetics of the antibody response to seasonal influenza vaccination among the elderly.

Kositanont U, Assantachai P, Wasi C, Puthavathana P, Praditsuwan R.

Viral Immunol. 2012 Dec;25(6):471-6. doi: 10.1089/vim.2012.0024. Epub 2012 Oct 12.

PMID:
23061793
[PubMed - indexed for MEDLINE]
11.

Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.

Kapetanovic MC, Saxne T, Nilsson JA, Geborek P.

Rheumatology (Oxford). 2007 Apr;46(4):608-11. Epub 2006 Nov 18.

PMID:
17114801
[PubMed - indexed for MEDLINE]
Free Article
12.

Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.

Montoya CJ, Toro MF, Aguirre C, Bustamante A, Hernandez M, Arango LP, Echeverry M, Arango AE, Prada MC, Alarcon Hdel P, Rojas M.

Mem Inst Oswaldo Cruz. 2007 Jun;102(4):501-8.

PMID:
17612772
[PubMed - indexed for MEDLINE]
Free Article
13.

Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.

Ribeiro AC, Guedes LK, Moraes JC, Saad CG, Aikawa NE, Calich AL, França IL, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky Mdo C, Precioso AR, Duarte A, Bonfa E, Laurindo IM.

Ann Rheum Dis. 2011 Dec;70(12):2144-7. doi: 10.1136/ard.2011.152983. Epub 2011 Aug 22.

PMID:
21859696
[PubMed - indexed for MEDLINE]
14.

Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.

Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.

Vaccine. 2009 Aug 27;27(39):5357-62. doi: 10.1016/j.vaccine.2009.06.082. Epub 2009 Jul 14.

PMID:
19607951
[PubMed - indexed for MEDLINE]
15.

Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.

Jo YM, Song JY, Hwang IS, Lee J, Oh SC, Kim JS, Kim SR, Kim WJ, Cheong HJ.

J Med Virol. 2009 Apr;81(4):722-7. doi: 10.1002/jmv.21186.

PMID:
19235853
[PubMed - indexed for MEDLINE]
16.

Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients.

Torii Y, Kimura H, Ochi N, Kaneko K, Ando H, Kiuchi T, Ito Y.

Vaccine. 2011 Jun 6;29(25):4187-9. doi: 10.1016/j.vaccine.2011.04.012. Epub 2011 Apr 20.

PMID:
21513762
[PubMed - indexed for MEDLINE]
17.

Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease.

Cullen G, Bader C, Korzenik JR, Sands BE.

Gut. 2012 Mar;61(3):385-91. doi: 10.1136/gutjnl-2011-300256. Epub 2011 Jul 13.

PMID:
21757451
[PubMed - indexed for MEDLINE]
18.

Immune response after influenza vaccination in children with cancer.

Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T.

Pediatr Blood Cancer. 2005 Nov;45(6):831-7.

PMID:
16007602
[PubMed - indexed for MEDLINE]
19.

Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.

Avila Aguero ML, Soriano-Fallas A, Umaña-Sauma MA, Ulloa-Gutierrez R, Arnoux S.

Medicina (B Aires). 2007;67(4):351-9.

PMID:
17891930
[PubMed - indexed for MEDLINE]
20.

Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine.

van Assen S, Holvast A, Telgt DS, Benne CA, de Haan A, Westra J, Kallenberg CG, Bijl M.

Clin Immunol. 2010 Aug;136(2):228-35. doi: 10.1016/j.clim.2010.03.430. Epub 2010 Apr 24.

PMID:
20421178
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk